Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 10 |
NetGPI | no | yes: 0, no: 10 |
Related structures:
AlphaFold database: A0A3Q8IB40
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 228 | 230 | PF00675 | 0.625 |
CLV_NRD_NRD_1 | 234 | 236 | PF00675 | 0.602 |
CLV_NRD_NRD_1 | 251 | 253 | PF00675 | 0.475 |
CLV_NRD_NRD_1 | 56 | 58 | PF00675 | 0.463 |
CLV_PCSK_KEX2_1 | 228 | 230 | PF00082 | 0.625 |
CLV_PCSK_KEX2_1 | 233 | 235 | PF00082 | 0.598 |
CLV_PCSK_KEX2_1 | 251 | 253 | PF00082 | 0.446 |
CLV_PCSK_KEX2_1 | 58 | 60 | PF00082 | 0.390 |
CLV_PCSK_PC1ET2_1 | 58 | 60 | PF00082 | 0.411 |
CLV_PCSK_PC7_1 | 229 | 235 | PF00082 | 0.663 |
CLV_PCSK_SKI1_1 | 150 | 154 | PF00082 | 0.606 |
CLV_PCSK_SKI1_1 | 228 | 232 | PF00082 | 0.652 |
CLV_PCSK_SKI1_1 | 77 | 81 | PF00082 | 0.445 |
CLV_PCSK_SKI1_1 | 94 | 98 | PF00082 | 0.224 |
DEG_APCC_KENBOX_2 | 195 | 199 | PF00400 | 0.578 |
DOC_CYCLIN_RxL_1 | 91 | 98 | PF00134 | 0.402 |
DOC_MAPK_gen_1 | 171 | 179 | PF00069 | 0.495 |
DOC_MAPK_gen_1 | 57 | 63 | PF00069 | 0.406 |
DOC_MIT_MIM_1 | 55 | 63 | PF04212 | 0.434 |
DOC_PP1_RVXF_1 | 40 | 47 | PF00149 | 0.430 |
DOC_PP4_FxxP_1 | 140 | 143 | PF00568 | 0.557 |
DOC_PP4_FxxP_1 | 152 | 155 | PF00568 | 0.545 |
DOC_PP4_FxxP_1 | 46 | 49 | PF00568 | 0.335 |
DOC_USP7_MATH_1 | 111 | 115 | PF00917 | 0.784 |
DOC_USP7_MATH_1 | 116 | 120 | PF00917 | 0.750 |
DOC_USP7_MATH_1 | 143 | 147 | PF00917 | 0.637 |
DOC_USP7_MATH_1 | 175 | 179 | PF00917 | 0.554 |
LIG_14-3-3_CanoR_1 | 150 | 155 | PF00244 | 0.641 |
LIG_14-3-3_CanoR_1 | 158 | 165 | PF00244 | 0.503 |
LIG_14-3-3_CanoR_1 | 228 | 237 | PF00244 | 0.537 |
LIG_deltaCOP1_diTrp_1 | 130 | 140 | PF00928 | 0.653 |
LIG_FHA_2 | 19 | 25 | PF00498 | 0.488 |
LIG_IRF3_LxIS_1 | 31 | 38 | PF10401 | 0.417 |
LIG_LIR_Apic_2 | 137 | 143 | PF02991 | 0.577 |
LIG_LIR_Gen_1 | 130 | 140 | PF02991 | 0.686 |
LIG_LIR_Gen_1 | 178 | 186 | PF02991 | 0.498 |
LIG_LIR_Gen_1 | 216 | 226 | PF02991 | 0.586 |
LIG_LIR_Gen_1 | 239 | 249 | PF02991 | 0.397 |
LIG_LIR_Gen_1 | 87 | 97 | PF02991 | 0.447 |
LIG_LIR_Nem_3 | 130 | 136 | PF02991 | 0.661 |
LIG_LIR_Nem_3 | 178 | 182 | PF02991 | 0.442 |
LIG_LIR_Nem_3 | 216 | 221 | PF02991 | 0.528 |
LIG_LIR_Nem_3 | 239 | 244 | PF02991 | 0.409 |
LIG_LIR_Nem_3 | 267 | 273 | PF02991 | 0.532 |
LIG_LIR_Nem_3 | 87 | 93 | PF02991 | 0.335 |
LIG_MAD2 | 42 | 50 | PF02301 | 0.363 |
LIG_NRBOX | 92 | 98 | PF00104 | 0.408 |
LIG_Pex14_2 | 152 | 156 | PF04695 | 0.630 |
LIG_SH2_CRK | 90 | 94 | PF00017 | 0.335 |
LIG_SH2_PTP2 | 270 | 273 | PF00017 | 0.518 |
LIG_SH2_STAP1 | 185 | 189 | PF00017 | 0.586 |
LIG_SH2_STAT5 | 217 | 220 | PF00017 | 0.569 |
LIG_SH2_STAT5 | 270 | 273 | PF00017 | 0.461 |
LIG_SH2_STAT5 | 90 | 93 | PF00017 | 0.480 |
LIG_TYR_ITIM | 268 | 273 | PF00017 | 0.522 |
MOD_CK1_1 | 114 | 120 | PF00069 | 0.701 |
MOD_CK1_1 | 145 | 151 | PF00069 | 0.593 |
MOD_CK1_1 | 163 | 169 | PF00069 | 0.519 |
MOD_CK2_1 | 163 | 169 | PF00069 | 0.602 |
MOD_Cter_Amidation | 249 | 252 | PF01082 | 0.515 |
MOD_GlcNHglycan | 114 | 117 | PF01048 | 0.695 |
MOD_GlcNHglycan | 118 | 121 | PF01048 | 0.709 |
MOD_GlcNHglycan | 122 | 125 | PF01048 | 0.677 |
MOD_GlcNHglycan | 18 | 21 | PF01048 | 0.685 |
MOD_GlcNHglycan | 224 | 227 | PF01048 | 0.553 |
MOD_GSK3_1 | 112 | 119 | PF00069 | 0.663 |
MOD_GSK3_1 | 156 | 163 | PF00069 | 0.658 |
MOD_GSK3_1 | 207 | 214 | PF00069 | 0.530 |
MOD_GSK3_1 | 236 | 243 | PF00069 | 0.628 |
MOD_GSK3_1 | 84 | 91 | PF00069 | 0.449 |
MOD_N-GLC_1 | 175 | 180 | PF02516 | 0.543 |
MOD_NEK2_1 | 16 | 21 | PF00069 | 0.652 |
MOD_NEK2_2 | 264 | 269 | PF00069 | 0.628 |
MOD_PKA_1 | 228 | 234 | PF00069 | 0.706 |
MOD_PKA_2 | 111 | 117 | PF00069 | 0.755 |
MOD_PKA_2 | 157 | 163 | PF00069 | 0.649 |
MOD_PKA_2 | 192 | 198 | PF00069 | 0.614 |
MOD_PKA_2 | 228 | 234 | PF00069 | 0.696 |
MOD_Plk_1 | 175 | 181 | PF00069 | 0.466 |
MOD_Plk_4 | 160 | 166 | PF00069 | 0.676 |
MOD_SUMO_rev_2 | 163 | 172 | PF00179 | 0.609 |
TRG_ENDOCYTIC_2 | 270 | 273 | PF00928 | 0.461 |
TRG_ENDOCYTIC_2 | 90 | 93 | PF00928 | 0.319 |
TRG_ER_diArg_1 | 227 | 229 | PF00400 | 0.642 |
TRG_ER_diArg_1 | 233 | 235 | PF00400 | 0.613 |
TRG_ER_diArg_1 | 251 | 254 | PF00400 | 0.497 |
TRG_ER_diArg_1 | 56 | 59 | PF00400 | 0.463 |
TRG_Pf-PMV_PEXEL_1 | 187 | 192 | PF00026 | 0.561 |
TRG_Pf-PMV_PEXEL_1 | 42 | 47 | PF00026 | 0.447 |
TRG_Pf-PMV_PEXEL_1 | 94 | 98 | PF00026 | 0.410 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1HRV7 | Leptomonas seymouri | 58% | 100% |
A0A0S4JQU3 | Bodo saltans | 31% | 100% |
A0A1X0NRW0 | Trypanosomatidae | 34% | 100% |
A0A3R7ND09 | Trypanosoma rangeli | 35% | 100% |
A4H693 | Leishmania braziliensis | 75% | 100% |
A4HUL6 | Leishmania infantum | 98% | 100% |
C9ZVP3 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 33% | 100% |
E9ANB5 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 90% | 100% |
Q4QHA9 | Leishmania major | 88% | 100% |